4.5 Review

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

期刊

BONE MARROW TRANSPLANTATION
卷 43, 期 10, 页码 757-770

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/bmt.2008.386

关键词

leukemia; SCT; HSV; VZV; EBV; guidelines

资金

  1. National Institute for Health Research

向作者/读者索取更多资源

These guidelines on the management of HSV, VZV and EBV infection in patients with hematological malignancies and after SCT were prepared by the European Conference on Infections in Leukemia following a predefined methodology. A PubMed search was conducted using the appropriate key words to identify studies pertinent to management of HSV, VZV and EBV infections. References of relevant articles and abstracts from recent hematology and SCT scientific meetings were also reviewed. Prospective and retrospective studies identified from the data sources were evaluated, and all data deemed relevant were included in this analysis. The clinical and scientific background was described and discussed, and the quality of evidence and level of recommendation were graded according to the Centers for Disease Control criteria. Bone Marrow Transplantation (2009) 43, 757-770; doi:10.1038/bmt.2008.386; published online 1 December 2008

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Microbiology

Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

Emilio Bouza, Miguel Martin, Jose Enrique Ales, Nuria Aragones, Begona Barragan, Rafael de la Camara, Jose Luis Del Pozo, Valentin Garcia-Gutierrez, Ramon Garcia-Sanz, Diego Gracia, Vicente Guillem, Victor Jimenez-Yuste, Mari Cruz Martin-Delgado, Joaquin Martinez, Rafael Lopez, Alvaro Rodriguez-Lescure, Julian Ruiz Galiana, Ana Maria Sureda, Francisco Tejerina-Picado, Antoni Trilla, Antonio Zapatero, Esteban Palomo, Jesus San-Miguel

Summary: The exact number of solid organ tumors diagnosed each year in Spain is unknown, making it difficult to determine if the pandemic has led to a decrease in cancer diagnoses. However, indirect data suggests that the pandemic has resulted in later-stage diagnoses for some non-hematological neoplasms. Although there is a lack of strong evidence, oncology patients who contract COVID-19 appear to have poorer outcomes. The immune response to infection in cancer patients is influenced by factors such as the type of neoplasia, treatment received, and timing of treatment.

REVISTA ESPANOLA DE QUIMIOTERAPIA (2023)

Article Biophysics

Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey

Moshe Yeshurun, Uri Rozovski, Liat Shargian, Oren Pasvolsky, Steffie van der Werf, Gloria Tridello, Nina Knelange, Malgorzata Mikulska, Jan Styczynski, Diana Averbuch, Rafael de la Camara

Summary: We conducted a study to describe the infection prevention practices among EBMT centers. Questionnaires were sent to all 553 centers and responses from 127 centers in 32 countries were obtained. The study revealed significant variations in antimicrobial prophylaxis practices, medications employed and duration of preventive therapy among the centers.

BONE MARROW TRANSPLANTATION (2023)

Article Oncology

Pediatric Acute Myeloid Leukemia Post Cytotoxic Therapy-Retrospective Analysis of the Patients Treated in Poland from 2005 to 2022

Malgorzata Czogala, Wojciech Czogala, Katarzyna Pawinska-Wasikowska, Teofila Ksiazek, Karolina Bukowska-Strakova, Barbara Sikorska-Fic, Pawel Laguna, Jolanta Skalska-Sadowska, Jacek Wachowiak, Anna Rodziewicz-Konarska, Malgorzata Moj-Hackemer, Krzysztof Kalwak, Katarzyna Muszynska-Roslan, Maryna Krawczuk-Rybak, Anna Falkowska, Katarzyna Drabko, Marta Kozlowska, Ninela Irga-Jaworska, Katarzyna Bobeff, Wojciech Mlynarski, Renata Tomaszewska, Tomasz Szczepanski, Agnieszka Chodala-Grzywacz, Grazyna Karolczyk, Katarzyna Mycko, Wanda Badowska, Karolina Zielezinska, Tomasz Urasinski, Natalia Bartoszewicz, Jan Styczynski, Walentyna Balwierz, Szymon Skoczen

Summary: The study aimed to identify the clinical characteristics and analyze the outcomes of pediatric AML-pCT. The data of 40 children with AML-pCT treated from 2005 to 2020 were retrospectively analyzed. The most common primary malignancies were acute lymphoblastic leukemia and brain tumors. The treatment outcomes improved significantly in patients treated from 2015-2022 compared to 2005-2014, with increased probabilities of EFS and RFS.

CANCERS (2023)

Article Biophysics

Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT

Jan Styczynski, Gloria Tridello, Linda Koster, Nina Knelange, Lotus Wendel, Anja van Biezen, Steffie van der Werf, Malgorzata Mikulska, Lidia Gil, Catherine Cordonnier, Per Ljungman, Diana Averbuch, Simone Cesaro, Helen Baldomero, Christian Chabannon, Selim Corbacioglu, Harry Dolstra, Bertram Glass, Raffaella Greco, Nicolaus Kroeger, Regis Peffault de Latour, Mohamad Mohty, Benedicte Neven, Zinaida Peric, John A. Snowden, Anna Sureda, Ibrahim Yakoub-Agha, Rafael de la Camara

Summary: This study analyzed the incidence and specific causes of death in HCT patients, focusing on infectious deaths. The results showed a decrease in mortality from infections in early phases but an increase in mortality from bacterial infections in the late phase.

BONE MARROW TRANSPLANTATION (2023)

Review Biotechnology & Applied Microbiology

Who is the patient at risk for EBV reactivation and disease: expert opinion focused on post-transplant lymphoproliferative disorders following hematopoietic stem cell transplantation

Agata Marjanska, Jan Styczynski

Summary: Post-transplant lymphoproliferative disorders (PTLD) are a diverse group of diseases caused by uncontrolled proliferation of lymphoid or plasmacytic cells resulting from T-cell immunosuppression after transplantation. These are mainly caused by latent Epstein-Barr virus (EBV), and the risk of EBV recurrence depends on the level of immune system incompetency.

EXPERT OPINION ON BIOLOGICAL THERAPY (2023)

Article Oncology

Infection With Saprochaete Clavata in Children After Hematopoietic Cell Transplantation

Tomasz Styczynski, Jagoda Sadlok, Monika Richert-Przygonska, Robert Debski, Patrycja Zalas-Wiecek, Krzysztof Czyzewski, Jan Styczynski

Summary: This paper reports two cases of pediatric patients with invasive fungal disease caused by Saprochaete clavata after allogeneic hematopoietic cell transplantation, and summarizes the literature data on this infection. With quick diagnosis and treatment, the outcome of therapy was successful.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2023)

Article Medicine, General & Internal

Extended List of Warning Signs in Qualification to Diagnosis and Treatment of Inborn Errors of Immunity in Children and Young Adults

Anna Dabrowska, Elzbieta Grzesk, Anna Urbanczyk, Marta Mazalon, Grzegorz Grzesk, Jan Styczynski, Sylwia Koltan

Summary: Inborn errors of immunity (IEI) are genetically determined disorders presenting with recurrent infections, autoimmunity, allergies, and malignancies. This study compared the utility of the 10 and 14 warning signs in diagnosing IEI. The results showed that the 14 warning signs are more effective in detecting IEI patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Oncology

Soluble Hemojuvelin and Ferritin: Potential Prognostic Markers in Pediatric Hematopoietic Cell Transplantation

Jan Styczynski, Artur Slomka, Monika Lecka, Katarzyna Albrecht, Michal Romiszewski, Monika Pogorzala, Malgorzata Kubicka, Beata Kurylo-Rafinska, Barbara Tejza, Grazyna Gadomska, Ewelina Kolanska-Dams, Malgorzata Michalska, Ewa Zekanowska

Summary: This study analyzed the prognostic impact of 12 serum iron metabolism parameters in children after intensive chemotherapy for acute leukemias (AL) or undergoing hematopoietic cell transplantation (HCT). High levels of ferritin and low levels of soluble hemojuvelin (sHJV) were found to have an adverse prognostic impact on overall survival (OS) and event-free survival (EFS) in children after HCT. The results were confirmed when combined with AL patients after intensive chemotherapy.

CANCERS (2023)

Letter Hematology

Neutropenia Secondary to SARS-Cov2 Vaccination in Post-Hematopoietic Stem Cell Transplant (HSCT) Patients

L. M. Juarez-Salcedo, S. Feijoo Monroy, C. Garcia-Herce, A. Alonso, B. Aguado, J. Ortiz, A. Figuera, de la Camara

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2023)

Article Biophysics

Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT

Jan Styczynski, Gloria Tridello, Lotus Wendel, Nina Knelange, Simone Cesaro, Lidia Gil, Per Ljungman, Malgorzata Mikulska, Dina Averbuch, Rafael de la Camara

Summary: The aim of this study was to examine the current approach to EBV-driven post-transplant complications in EBMT transplant centers. The study found that most centers conduct routine serology testing before HCT, while some also routinely test for pretransplant EBV-DNA. Monitoring for EBV infection is feasible in almost all centers, with some using standardized PCR. Regular post-HCT monitoring is performed in the majority of centers. Prophylaxis with rituximab is used in a small percentage of centers. The prevalence of csEBV-DNA-emia was 7.4%, with higher rates in children. The frequency of EBV-PTLD was 1.6%, with higher rates in children. Rituximab and reduction of immunosuppressive therapy were the first-line treatments for EBV-driven complications. The failure rate of first-line preemptive treatment was 12.0%. EBV-specific T-lymphocytes were available in a portion of centers. Experimental therapies were given to patients with resistant/refractory PTLD. Overall, the prevalence of EBV-DNA-emia and EBV-PTLD decreased in comparison to historical data.

BONE MARROW TRANSPLANTATION (2023)

Letter Biophysics

Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT

Giorgia Battipaglia, Jarl E. Mooyaart, Ralf Meyer, Mohamad Mohty, Alicja Sadowska-Klasa, Oleg Goloshchapov, Franco Locatelli, Jan Styczynski, Jiri Pavlu, Jaroslaw Dybko, Gleb Bronin, Urpu Salmenniemi, Pavel Jindra, Jorinde D. Hoogenboom, Jurgen Kuball, Annalisa Ruggeri, Florent Malard

BONE MARROW TRANSPLANTATION (2023)

Letter Oncology

Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)

Simone Cesaro, Malgorzata Mikulska, Hans H. Hirsch, Jan Styczynski, Sylvain Meylan, Catherine Cordonnier, Davide Navarro, Marie von Lilienfeld-Toal, Varun Mehra, Francesco Marchesi, Caroline Besson, Raul Cordoba Masculano, Gernot Beutel, Herman Einsele, Johan Maertens, Rafael de la Camara, Per Ljungman, Livio Pagano

LEUKEMIA (2023)

Article Oncology

Characteristics and Outcome of FLT3-ITD-Positive Pediatric Acute Myeloid Leukemia-Experience of Polish Pediatric Leukemia and Lymphoma Study Group from 2005 to 2022

Malgorzata Czogala, Wojciech Czogala, Katarzyna Pawinska-Wasikowska, Teofila Ksiazek, Karolina Bukowska-Strakova, Barbara Sikorska-Fic, Pawel Laguna, Anna Falkowska, Katarzyna Drabko, Katarzyna Muszynska-Roslan, Maryna Krawczuk-Rybak, Marta Kozlowska, Ninela Irga-Jaworska, Karolina Zielezinska, Tomasz Urasinski, Natalia Bartoszewicz, Jan Styczynski, Jolanta Skalska-Sadowska, Jacek Wachowiak, Anna Rodziewicz-Konarska, Krzysztof Kalwak, Malgorzata Ciebiera, Radoslaw Chaber, Agnieszka Mizia-Malarz, Agnieszka Chodala-Grzywacz, Grazyna Karolczyk, Katarzyna Bobeff, Wojciech Mlynarski, Katarzyna Mycko, Wanda Badowska, Renata Tomaszewska, Tomasz Szczepanski, Katarzyna Machnik, Natalia Zamorska, Walentyna Balwierz, Szymon Skoczen

Summary: Mutations in the FLT3 gene are associated with poor outcomes in pediatric AML. A retrospective analysis of a nationwide pediatric AML database showed that FLT3-ITD-positive patients had worse survival compared to FLT3-ITD-negative patients. Treatment protocols and the use of FLT3 inhibitors and stem cell transplantation showed potential for improving outcomes. Additional genetic mutations, such as WT1 and NPM1, significantly influenced prognosis.

CANCERS (2023)

Article Medicine, General & Internal

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis

Emilia Roy-Vallejo, Sara Fernandez De Cordoba-Onate, Pablo Delgado-Wicke, Ana Triguero-Martinez, Nuria Montes, Rosa Carracedo-Rodriguez, Nelly Zurita-Cruz, Ana Marcos-Jimenez, Amalia Lamana, Jose Maria Galvan-Roman, Gonzalo Villapalos Garcia, Pablo Zubiaur, Marianela Ciudad, Laura Rabes, Marta Sanz, Carlos Rodriguez, Almudena Villa, Jesus alvarez Rodriguez, Celeste Marcos, Julia Hernando, Paula Diaz-Fernandez, Francisco Abad, Ignacio de los Santos, Diego A. Rodriguez Serrano, Rosario Garcia-Vicuna, Carmen Suarez Fernandez, Rosa P. Gomariz, Cecilia Munoz-Calleja, Elena Fernandez-Ruiz, Isidoro Gonzalez-Alvaro, Laura Cardenoso, PREDINMUN COVID Grp

Summary: This study aimed to evaluate the relationship between SARS-CoV-2 viremia and specific gene SNPs in predicting COVID-19 severity. Genetic variants in HMOX1, SERPING1, TMPRSS2, CD69, TRAF3IP2, OAS1, and VIPR1 genes could explain the heterogeneity in SARS-CoV-2 viremia in our population.

FRONTIERS IN MEDICINE (2023)

暂无数据